Literature DB >> 1930911

Cytokines in rheumatoid arthritis.

A Ridderstad1, M Abedi-Valugerdi, E Möller.   

Abstract

Joints with rheumatoid arthritis are a site for chronic inflammation involving T cells, B cells, macrophages and dendritic cells. When these cells interact cytokines are likely to be produced. The presence of different cytokines in the synovial fluid of patients with rheumatoid arthritis has been studied and the macrophage derived cytokines such as IL-1, IL-6, TNF-alpha, TGF-beta and PDGF have usually been detected in large quantities, whereas T cell produced cytokines (IL-2, IL-4, IFN-gamma) are absent or present in small quantities. IL-1, IL-6 and TNF-alpha have several functions which suggest that they participate in the chronic disease process of rheumatoid arthritis, such as increasing production of eicosanoid, collagenase and prostaglandin E2. Many synovial B cells are activated and produce large amounts of immunoglobulins. We searched for a B cell stimulatory activity in rheumatoid synovial fluid and found a B cell differentiation and helper activity. Cytokines in the joints of patients with rheumatoid arthritis seem central for the propagation of the disease process. Specific intervention in cytokine production or in its effects might help to relieve symptoms in rheumatoid patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930911     DOI: 10.3109/07853899109148051

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  15 in total

1.  Therapeutic effect of Saraca asoca (Roxb.) Wilde on lysosomal enzymes and collagen metabolism in adjuvant induced arthritis.

Authors:  Subramanian Saravanan; Narasimhan Prakash Babu; Perumal Pandikumar; Savarimuthu Ignacimuthu
Journal:  Inflammopharmacology       Date:  2011-09-23       Impact factor: 4.473

2.  Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis.

Authors:  L Tissi; M Puliti; R Barluzzi; G Orefici; C von Hunolstein; F Bistoni
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells.

Authors:  T Iwata; A Mitani; Y Ishihara; S Tanaka; G Yamamoto; T Kikuchi; T Naganawa; Y Matsumura; T Suga; M Koide; T Sobue; T Suzuki; T Noguchi
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

5.  Paraoxonase and arylesterase levels in rheumatoid arthritis.

Authors:  A Isik; S S Koca; B Ustundag; H Celik; A Yildirim
Journal:  Clin Rheumatol       Date:  2006-04-27       Impact factor: 2.980

6.  Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion.

Authors:  T Sentürk; G Kinikli; M Turgay; H Tutkak; M Duman; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

8.  IL1-beta and TNF-alpha induce changes in the nuclear polyphosphoinositide signalling system in osteoblasts similar to that occurring in patients with rheumatoid arthritis: an immunochemical and immunocytochemical study.

Authors:  Nicoletta Zini; Gina Lisignoli; Liliana Solimando; Alberto Bavelloni; Francesco Grassi; Lia Guidotti; Carmela Trimarchi; Andrea Facchini; Nadir Mario Maraldi
Journal:  Histochem Cell Biol       Date:  2003-08-12       Impact factor: 4.304

9.  R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.

Authors:  M Jongen-Lavrencic; H R Peeters; B Backx; I P Touw; G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.

Authors:  J A Cirelli; C H Park; K MacKool; M Taba; K H Lustig; H Burstein; W V Giannobile
Journal:  Gene Ther       Date:  2008-12-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.